SBIR/STTR Research Award

Kit for global RNP profiling

Award identifier fbc3fa2cf43e559f4d5df8990e228a813df5b0974e7b47a4b1a520dd2b8bf567Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$158,902

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Caribou Biosciences, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PA12-088
Topic code
NIGMS

Research abstract

DESCRIPTION (provided by applicant): RNAs and ribonucleoprotein complexes (RNPs) play central roles in biology and disease. Despite their importance to both basic and clinical biology, there is no general methodology to study the composition and function of RNPs isolated from their native context. To address this need, our Phase I goal is to develop a new and robust affinity separation technology for RNP complexes. In Phase II, we propose to develop the method into an easy-to-use kit that can be employed byresearchers to detect and analyze specific RNPs in their laboratories without special expertise for a variety of applications. Our strategy is based on an endoribonuclease that binds a specific RNA sequence with very high affinity and cleaves this sequence at a single site. A mutant version of this protein can bind but not cleave target RNA. In our method, a target RNA will be expressed in vitro or in vivo with a 5' tag composed of the endoribonuclease target sequence. Cellular extracts will be applied tothe mutant endoribonuclease immobilized on resin. The tagged RNA will be trapped by the mutant endoribonuclease. Under specific buffer conditions, cleavage activity of the mutant endoribonuclease can be reactivated, causing the tag to be cleaved off, liberating the target RNA and any protein partners bound to it. The isolated RNA and its associated RNA binding proteins can then be analyzed by a variety of molecular biological or biophysical techniques. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: Recent deep sequencing experiments have revealed that as much as 20 times more of the human genome is transcribed into noncoding RNAs (RNAs that don't get translated into proteins) than is transcribed into protein-coding messenger RNAs. Many of thesenoncoding RNAs have been implicated in various cancers and diseases, but little is known about their normal or disease-related cellular functions because there is no general method for purifying and studying these RNAs and the proteins to which they bind.By developing an RNA affinity purification technology, we can begin to shed light on the normal functions of these RNAs and how they may play a role in various diseases.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.